Comparison of The Efficacy and Safety of Penicillins and Cephalosporins In Treatment of Pediatric Patients With Lower Respiratory Tract Infections

ABSTRACT The most common Lower respiratory tract infections (LRTI) such as bronchopneumonia, acute bronchiolitis, acute bronchitis. These infections are caused by numerous pathogens, among them virus as well as bacteria are more common. During the period of disease child and the parents also suffer with mental agony in addition to economic loss to the family. This study was conducted to assess and compare the efficacy and safety of penicillins and cephalosporins in treatment of pediatric patients with lower respiratory tract infections (LRTI).This prospective data collection study was conducted in the Department of Pediatrics, Narayana Medical College & Hospital, Nellore. The study was conducted after obtaining permission from Institutional Ethical Committee (IEC) for a period of six months. Fifty hospitalized patients with lower respiratory tract infections were enrolled into the study. Twenty five patients were treated with penicillins and remaining twenty five received cephalosporins. We analyzed the efficacy and safety based on the available data in medical case sheets of patients and also by collecting information from patients or parent of the patients.The mean time for disappearance of cough in the cephalosporin group was significantly lower than penicillin group (p=0.0001). However the time to disappearance of fever and breathlessness was not significantly different between the two groups (p=0.09, p=0.17). The mean time to improvement in all the clinical signs such as wheeze, crepitations and abnormal respiratory rate were in the cephalosporin group was significantly lower than penicillin group (p=0.001,p=0.01,p=0.02). Based on the present study, the clinical cure was observed in all the patients without any residual sequel and no adverse effects were reported. Hence, by our study it can be concluded that both groups of antibiotics were effective and safe.

[1]  A. Pareek,et al.  Randomized, Multicentre, Comparative Clinical Evaluation of Cefuroxime–Sulbactam versus Amoxicillin–Clavulanic Acid Therapy in the Treatment of Lower Respiratory Tract Infections , 2008, The Journal of international medical research.

[2]  M. Kulkarni,et al.  Comparative evaluation of efficacy and safety of cefotaxime-sulbactam with amoxicillin-clavulanic acid in children with lower respiratory tract infections , 2008, Expert opinion on pharmacotherapy.

[3]  R. Leone,et al.  Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy. , 2007, The Journal of antimicrobial chemotherapy.

[4]  D. Isaacs,et al.  Bacteraemia and antibiotic use in respiratory syncytial virus infections , 2004, Archives of Disease in Childhood.

[5]  J. Kimpen Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing , 2002, Respiratory research.

[6]  D. J. Burch,et al.  International variation in the management of infants hospitalized with respiratory syncytial virus , 1998, European Journal of Pediatrics.

[7]  J. Feris,et al.  Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia. , 1996, The Journal of antimicrobial chemotherapy.

[8]  C. Brambilla,et al.  Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[9]  K. Park,et al.  Text book of preventive and social medicine , 1989 .

[10]  G. Simon,et al.  Efficacy of ceftriaxone in serious bacterial infections , 1982, Antimicrobial Agents and Chemotherapy.

[11]  P. Minns,et al.  A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients. , 1995, Journal of chemotherapy.

[12]  A. Tattersfield,et al.  Lower Respiratory Tract Infections , 1987 .

[13]  L. Humair,et al.  Treatment of severe lower respiratory tract infections with ceftriaxone (Ro 13-9904). A pilot study. , 1981, Chemotherapy.